Novel Wild-Type Pediococcus and Lactiplantibacillus Strains as Probiotic Candidates to Manage Obesity-Associated Insulin Resistance
- PMID: 38399636
- PMCID: PMC10891751
- DOI: 10.3390/microorganisms12020231
Novel Wild-Type Pediococcus and Lactiplantibacillus Strains as Probiotic Candidates to Manage Obesity-Associated Insulin Resistance
Abstract
As the food and pharmaceutical industry is continuously seeking new probiotic strains with unique health properties, the aim of the present study was to determine the impact of short-term dietary intervention with novel wild-type strains, isolated from various sources, on high-fat diet (HFD)-induced insulin resistance. Initially, the strains were evaluated in vitro for their ability to survive in simulated gastrointestinal (GI) conditions, for adhesion to Caco-2 cells, for bile salt hydrolase secretion, for cholesterol-lowering and cellular cholesterol-binding ability, and for growth inhibition of food-borne pathogens. In addition, safety criteria were assessed, including hemolytic activity and susceptibility to antibiotics. The in vivo test on insulin resistance showed that mice receiving the HFD supplemented with Pediococcus acidilactici SK (isolated from human feces) or P. acidilactici OLS3-1 strain (isolated from olive fruit) exhibited significantly improved insulin resistance compared to HFD-fed mice or to the normal diet (ND)-fed group.
Keywords: Lactiplantibacillus; Pediococcus; high-fat diet; insulin resistance; obesity; probiotics; type2 diabetes.
Conflict of interest statement
Author Panayiotis Panas was employed by QLCon. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures



References
-
- FAO/WHO . Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food. FAO/WHO; London, ON, Canada: 2002.
-
- Al-Emran H.M., Moon J.F., Miah M.L., Meghla N.S., Reuben R.C., Uddin M.J., Ibnat H., Sarkar S.L., Roy P.C., Rahman M.S., et al. Genomic Analysis and in Vivo Efficacy of Pediococcus Acidilactici as a Potential Probiotic to Prevent Hyperglycemia, Hypercholesterolemia and Gastrointestinal Infections. Sci. Rep. 2022;12:20429. doi: 10.1038/s41598-022-24791-5. - DOI - PMC - PubMed
-
- Balakumar M., Prabhu D., Sathishkumar C., Prabu P., Rokana N., Kumar R., Raghavan S., Soundarajan A., Grover S., Batish V.K., et al. Improvement in Glucose Tolerance and Insulin Sensitivity by Probiotic Strains of Indian Gut Origin in High-Fat Diet-Fed C57BL/6J Mice. Eur. J. Nutr. 2018;57:279–295. doi: 10.1007/s00394-016-1317-7. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials